Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on March 2nd, 2017 by Dr. Makarand Jawadekar, Ph.D in Pharma R&D
Cancer. It’s the 2nd leading cause of death in this country (1), and a disease feared by patients and healthcare professionals alike. Today’s cancer treatments vary in nature, and also, efficacy and levels of side effect profiles. Continue reading “Emerging Oncology Drugs in Pharma R&D Pipeline” »
Posted on November 18th, 2016 by Betsy Davis in Pharma R&D
Munich-based biopharma start-up multimmune GmbH is in our spotlight this week due to the company’s inspired research efforts. Professor A. Graham Pockley, Chief Executive Officer of multimmune, discusses how they are working towards the development of more cost-effective cancer treatments. Continue reading “Start-up Spotlight: Multimmune GmbH” »
Posted on October 20th, 2016 by Betsy Davis in Pharma R&D
Drug discovery and development was once a very secretive process where the major industry players were intent on keeping their research to themselves in order to stay competitive.